- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00915499
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study (CompSAS)
February 22, 2013 updated by: ResMed
Is Adaptive Servo-Ventilation Therapeutically More Effective Than Continuous Positive Airway Pressure In Treating Complex Sleep Apnea Syndrome?
The purpose of this study is to determine whether adaptive servo-ventilation (ASV) or continuous positive airway pressure (CPAP) is better at treating complex sleep apnea over time.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Between 3 and 19% of patients with clinical and polysomnographic features of obstructive sleep apnea syndrome (OSA) develop a high-frequency of central apneas and/or disruptive Cheyne-Stokes respiratory syndrome after application of continuous positive airway pressure (CPAP), a pattern called the complex sleep apnea syndrome (CompSAS).
The trial seeks to determine the efficacy of the ASV vs. CPAP modes for the treatment of CompSAS over time.
Baseline clinical and laboratory data will be collected, patients will be randomized to one of the two treatments.
Overall study participation is approximately 3 months.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85037
- REM Medical
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
Skokie, Illinois, United States, 60077
- NorthShore University Health System
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Center for Sleep Medicine, Mayo Clinic
-
-
Pennsylvania
-
Lafayette Hill, Pennsylvania, United States, 19444
- Center for Sleep Medicine
-
-
South Carolina
-
Columbia, South Carolina, United States, 29201
- Sleepmed of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of complex sleep apnea syndrome (CompSAS)
- Naive to PAP therapy
- Requires CPAP ≤15 cm H2O
Exclusion Criteria:
- Requires supplemental oxygen or with a baseline SaO2 <90%
- Requires CPAP > 15 cm H2O
- Primary diagnosis of moderate to severe chronic obstructive pulmonary disease, neuromuscular disease, chronic hyperventilation, stroke, cognitive impairment, such that could impair ability to answer subjective questions (study questionnaires) or unstable heart failure
- Any contraindication for nasal or oro-nasal positive airway pressure, such as claustrophobia, severe nasal obstruction, or impaired mental status
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: ASV mode
|
Comparison of ASV and CPAP modes
|
|
ACTIVE_COMPARATOR: CPAP mode
|
Comparison of ASV and CPAP modes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Apnea-hypopnea Index (AHI) Per Polysomnography (PSG) at the End of Treatment Period
Time Frame: 3 months
|
AHI refers to the number of apneas and hypopneas that occurred per hour of sleep
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life Measured by the Sleep Apnea Quality of Life Index (SAQLI)
Time Frame: 3 months
|
Likert scale measured from 0-7.
The minimum important difference a change of 0.5 when a 7-item Likert scale is used.
0 represents the most negative response, 7 represents the most positive response.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Timothy I Morgenthaler, MD, Mayo Sleep Disorders Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (ACTUAL)
October 1, 2011
Study Completion (ACTUAL)
December 1, 2011
Study Registration Dates
First Submitted
June 4, 2009
First Submitted That Met QC Criteria
June 5, 2009
First Posted (ESTIMATE)
June 8, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
February 28, 2013
Last Update Submitted That Met QC Criteria
February 22, 2013
Last Verified
February 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CA-01-08
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complex Sleep Apnea Syndrome
-
University Hospital, MontpellierCompletedComplex Sleep Apnea Syndrome | Chronic Heart Failure and | Obstructive Sleep Apnea Syndrome and | Idiopathic Central Sleep Apnea Syndrome | Idiopathic Induced Periodic Breathing | Central Sleep Apnea SyndromeFrance
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
-
ResMedCRI-The Clinical Research Institute GmbH; University Hospital RegensburgCompletedObstructive Sleep Apnea | Central Sleep Apnea | Mixed Sleep Apnea | Complex Sleep ApneaSwitzerland, Spain, Denmark, Portugal, France, Germany
-
University Hospital, AntwerpEnrolling by invitationSleep Apnea | Sleep Apnea Syndrome | Sleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS)Belgium
-
Krankenhaus Kloster GrafschaftCompletedComplex Sleep Apnea | CPAP Induced Central Sleep ApneaGermany
-
University Medicine GreifswaldEnrolling by invitation
-
Philips RespironicsCompletedCheyne-Stokes Respiration | Central Sleep Apnea | Mixed Sleep Apnea | Complex Sleep ApneaGermany
-
Centre Hospitalier de ValenceCompletedObstructive Sleep Apnea/Hypopnea SyndromeFrance
-
University of ChicagoGlaxoSmithKlineCompletedChildhood Obstructive Sleep Apnea Syndrome (OSAS)United States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...VU University of Amsterdam; Amsterdam Medical Center (AMC)RecruitingSleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS)Netherlands
Clinical Trials on VPAP Adapt SV
-
ResMedCRI-The Clinical Research Institute GmbHCompletedHeart Failure | Sleep Disordered BreathingGermany, Netherlands, Australia, Denmark, France, United Kingdom, Switzerland, Norway, Finland, Sweden, Czechia
-
ResMedCompletedPeriodic Breathing | Breathing-Related Sleep DisorderGermany
-
Washington University School of MedicineUniversity of Rochester; ResMed Foundation; The Hebrew University Hadassah Medical...TerminatedObstructive Sleep Apnea | Pregnancy Related | Fetal Growth RestrictionUnited States, Israel
-
Philips RespironicsCompleted
-
ResMedCompletedCheyne-Stokes Respiration | Periodic BreathingGermany
-
University of ArizonaPhilips RespironicsUnknownHeart Failure | Sleep Apnea, Mixed
-
MetroHealth Medical CenterResMed; Great Lakes NeuroTechnologies Inc.TerminatedObstructive Sleep ApneaUnited States
-
University Hospital, BrestMinistry of Health, FranceCompletedSurgery for Primary Lung CancerFrance
-
University of MinnesotaCompletedParentingUnited States